Development and implementation of a novel metric score (SciMet) for scientific publications

Keyphrases

• Gynecologic Oncology 100%
• Metric Scores 100%
• Novel Metrics 100%
• Ovarian Cancer 66%
• Multiparametric Scores 66%
• Cervical Cancer 33%
• Cancer Development 33%
• PubMed 33%
• Scoring System 33%
• Bevacizumab 33%
• Cervical Intraepithelial Neoplasia 33%
• Randomized Clinical Trial 33%
• Numerics 33%
• High-score 33%
• Clinical Impact 33%
• Quality Measures 33%
• Vaccine Impact 33%
• Gynecological Cancer 33%
• Screening Interventions 33%
• PARP Inhibitor (PARPi) 33%
• Surgical Trials 33%
• Cancer Vaccination 33%
• Change Management 33%
• Top 10 33%
• HPV Vaccine 33%
• Journal Impact Factor 33%
• Top 100 33%
• Factor Study 33%
• Citation Metrics 33%
• Altmetric Attention Score 33%
• Influential Articles 33%
• First-line Maintenance 33%
• Transformative Value 33%
• Cervical HPV 33%

Medicine and Dentistry

• Ovarian Cancer 100%
• Gynecological Oncology 100%
• Malignant Neoplasm 50%
• Oncology 50%
• Cervical Cancer 50%
• Scoring System 50%
• Bevacizumab 50%
• Cervical Intraepithelial Neoplasia 50%
• Female Genital Tract Cancer 50%
• Gynecology 50%
• PARP Inhibitor 50%
• Randomized Clinical Trials 50%